This site is intended for healthcare professionals only
LoginRegister
Bristol Myers Squibb heart disease drug fails to meet main goals in late-stage studyBristol Myers Squibb gets European Commission nod for Breyanzi for follicular lymphoma
Delhi HC grants relief to zydus healthcare in biochem trademark caseCDSCO Panel suggests revising phase III CT protocol of Zydus Healthcare's Empagliflozin plus...
Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIAConduct BE study or present safety data: CDSCO Panel tells IQVIA on anti-cancer Drug Daratumumab...
USFDA concludes inspection at Shilpa Medicare Raichur unitUSFDA concludes inspection at Shilpa Medicare Raichur unit
Alkem Labs Adil Billimoria steps downUSFDA inspection: Alkem Labs concludes inspection at Taloja Center
JB Chemicals Panoli facility concludes USFDA inspection no observationsJB Chemicals and Pharma Panoli facility concludes USFDA inspection no observations
USFDA concludes inspection at Zydus Lifesciences Ankleshwar facilityUSFDA concludes inspection at Zydus Lifesciences Ankleshwar facility
1471 drugs samples manufactured in HP failed quality tests in past two years: Minister1471 drugs samples manufactured in HP failed quality tests in past two years: Minister
Modify Phase III CT protocol: CDSCO panel Tells Windlas Biotech on FDC Tamsulosin plus MirabegronModify Phase III CT protocol: CDSCO panel Tells Windlas Biotech on FDC Tamsulosin plus Mirabegron
Synokem Pharmaceutical Gets CDSCO Panel Nod To Study Anti-rheumatoid drug IguratimodSynokem Pharmaceutical Gets CDSCO Panel Nod To Study Anti-rheumatoid drug Iguratimod
Cardiac, GI Power Indian Pharma Markets 7.5% March SurgeIndian Pharma Market Grows 7.5% in Feb 2025, But Respiratory Segment Declines by 4.6%
CagriSema demonstrates superior weight loss in adults with obesity, type 2 diabetes in REDEFINE 2 trial: Novo NordiskCagriSema demonstrates superior weight loss in adults with obesity, type 2 diabetes in REDEFINE 2...
X